Standard BioTools Inc. (LAB) — Stock Score Summary

Standard BioTools Inc. (LAB) has a MoatMap StockRank of 24/100 based on Quality (40/100), Value (43/100), and Momentum (27/100) factor scores. The current signal is SELL. Standard BioTools provides life science analytical instruments. The company has struggled with profitability and is undergoing a complex turnaround, which violates our core rule of avoiding turnarounds in favor of established compounders.

Standard BioTools develops, manufactures, and markets innovative research tools for life science, including instruments, reagents, and software for single-cell analysis and genomics. Its proprietary microfluidics technology enables high-throughput, high-resolution biological analysis crucial for academic, clinical, and pharmaceutical research. The company is a key provider of advanced analytical platforms that facilitate breakthroughs in precision medicine and scientific discovery.

Key Financial Metrics

Price$0.89
Market Cap$445M
P/E (Forward)-127.00
Price/Book0.88
Return on Equity-9.9%
Return on Invested Capital-21.0%
Debt/Equity5.26
Gross Margin53.3%
Operating Margin-44.5%
Revenue Growth4.6%
Free Cash Flow$-13M

Standard BioTools Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Standard BioTools Inc.’s (LAB) StockRank?
MoatMap’s StockRank for Standard BioTools Inc. (LAB) is 24/100, with a Sell signal. It is a composite of Quality (40), Value (43), and Momentum (27) factor ranks across MoatMap’s 19,000+ stock universe.
Does Standard BioTools Inc. have an economic moat?
Standard BioTools Inc. (LAB) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Standard BioTools Inc. a buy, hold, or sell?
MoatMap’s current signal for Standard BioTools Inc. (LAB) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Standard BioTools Inc. in?
Standard BioTools Inc. (LAB) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksLAB deep dive reportAI ChampionsHow we score stocksSense-check another stock